| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-07 |